Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2023-11-29 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
董事会审计委员会实施细则
Governance Information Classification · 95% confidence The document is titled '董事会审计委员会实施细则' which translates to 'Board Audit Committee Implementation Rules'. It details the structure, responsibilities, procedures, and governance of the company's audit committee. It does not contain financial statements, audit results, or financial performance data. Instead, it outlines governance and procedural rules related to the audit committee's operation within the board. This fits the description of a Governance Information (CGR) filing, which covers internal rules, board structure, and governance practices. The document length is 2669 characters, which is relatively short but contains substantive governance content rather than being a mere announcement or certification. Therefore, the appropriate classification is CGR with high confidence.
2023-11-29 Chinese
董事会提名委员会实施细则
Governance Information Classification · 95% confidence The document is titled '董事会提名委员会实施细则' which translates to 'Board Nomination Committee Implementation Rules'. It details the structure, responsibilities, procedures, and rules governing the nomination committee of the board of directors. There is no financial data, no mention of financial results, no regulatory filings or announcements, and no indication of a meeting or voting results. The content focuses on governance practices related to board nominations and management appointments. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 2330 characters, which is sufficient for a detailed governance report but too short for a full annual or interim report. Therefore, the classification is Governance Information (CGR) with high confidence.
2023-11-29 Chinese
关于召开2023年第六次临时股东大会通知
AGM Information Classification · 95% confidence The document is a notice for convening the 2023 sixth extraordinary general meeting of shareholders of Tiankang Biological Co., Ltd. It includes details about the meeting date, voting procedures, agenda items, and proxy authorization. It does not contain financial statements, audit results, or earnings data. It is a formal announcement about the meeting itself, not the meeting materials or results. The document length is 4207 characters, which is relatively short and consistent with a meeting notice. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or related to the Annual or Extraordinary General Meeting, including notices of meetings.
2023-11-29 Chinese
董事会薪酬与考核委员会实施细则
Governance Information Classification · 95% confidence The document is titled as the 'Implementation Rules of the Board Remuneration and Assessment Committee' of Tian Kang Biological Co., Ltd. It details the structure, responsibilities, composition, and procedures of the remuneration and assessment committee within the board of directors. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, and no mention of any regulatory filing or report publication. The content focuses on governance practices related to board remuneration and assessment policies. Therefore, the document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-11-29 Chinese
公司章程(2023年11月修订）
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for Tian Kang Biology Co., Ltd. It includes comprehensive sections on company organization, shareholder rights, board structure, share issuance, shareholder meetings, and governance rules. It references Chinese company law and securities regulations, and outlines the company's internal rules and governance practices. There is no indication that this is an annual report, financial statement, earnings release, or any other financial filing. Instead, it is a governance document detailing the company's internal rules and structure. Therefore, the appropriate classification is Governance Information (CGR). The document length and content confirm it is not a mere announcement or summary but a full governance report.
2023-11-29 Chinese
独立董事管理办法
Governance Information Classification · 100% confidence The document is titled '独立董事管理办法' which translates to 'Independent Director Management Measures' and contains detailed rules and procedures regarding the qualifications, duties, meetings, and protections of independent directors within the company. It references relevant laws, regulations, and governance practices. The content is focused on governance structure and internal rules rather than financial results, audit opinions, or shareholder meeting materials. It is a governance-related document outlining internal rules and practices for independent directors. Therefore, it fits best under the category of Governance Information (CGR). The document length is substantial and contains detailed governance policies, not just an announcement or summary, so it is not an RPA or RNS.
2023-11-29 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.